查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423584

2030 年支氣管鏡市場預測：按產品類型、組件、用途、應用、最終用戶和地區進行的全球分析

Bronchoscopy Market Forecasts to 2030 - Global Analysis By Product Type (Bronchoscopes), By Component (Imaging Systems, Accessories and Other Components) Usage, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球支氣管鏡市場規模為 27 億美元，預計在預測期內複合年成長率為 9.9%，到 2030 年將達到 53 億美元。

支氣管鏡檢查是一種醫療程序，可讓您查看並評估您的肺部和氣道。支氣管鏡是一根細而柔韌的管子，可透過您的口腔或鼻子插入喉嚨，然後進入呼吸道。支氣管鏡檢查可以直接觀察呼吸系統，從而可以治療和診斷各種肺部疾病。

根據國際呼吸學會論壇2022年報告，估計約有2億人患有慢性阻塞性肺病，2.62億人患有氣喘。由於此類呼吸系統疾病的高盛行率和癌症患者數量的不斷增加，預計用於診斷這種疾病的支氣管鏡檢查的需求將會增加，並最終推動市場的發展。

呼吸系統疾病和肺部負擔增加

肺癌、慢性阻塞性肺病(COPD)、氣喘、肺炎和結核病等呼吸系統疾病的盛行率不斷增加，增加了對支氣管鏡檢查等診斷程序的需求。支氣管鏡檢查對於獲取組織樣本和評估氣道以進行正確診斷也至關重要，因為這些疾病通常需要準確的分期和診斷。隨著患者在肺部相關疾病方面偏好轉向侵入性較小的方法，支氣管鏡檢查提供了開放性手術的替代方案，從而促進了市場成長。

製造成本高、應用困難

管理費用的急劇上升可能會導致用於支付這些費用的程序和課稅價格上漲。這可能會增加患者、保險公司和政府醫療保健計劃的費用，從而對醫療保健預算以及付款人和患者的負擔能力產生負面影響。在管理費用過高的地區，提供支氣管鏡檢查的醫院較少，導致支氣管鏡檢查分佈不均。因此，先進診斷和治療性支氣管鏡檢查服務的可用性可能存在差異，這可能會影響患者護理。

支氣管鏡檢查的技術進步

先進的支氣管鏡技術可以實現氣道內的各種治療方法，包括消融、支氣管熱成形術、切片檢查、支架置入、腫瘤切除和去除異物。這些功能增加了支氣管鏡檢查在治療應用上的效用，並將其擴展到非診斷應用。此外，虛擬支氣管鏡和現代成像設備，包括電磁導航支氣管鏡（ENB）和支氣管內超音波（EBUS），可以對氣道和周圍結構進行全面、即時的成像，推動市場成長。我們對此表示支持。

併發症的風險

醫療機構和提供者可能會因支氣管鏡檢查手術後的併發症而面臨責任問題。醫療保健專業人員必須遵守嚴格的護理標準和通訊協定，以減少困難並防止潛在的訴訟。這增加了支氣管內治療的複雜性和謹慎性。如果出現問題，可能會引起監管機構的注意，監管機構可能會對支氣管鏡檢查實施更嚴格的政策和品管流程。為了保持合規性，醫療保健組織可能必須證明他們遵循嚴格的指導方針，這可能會影響他們的運作方式和資源使用方式，從而阻礙市場成長。這是有可能的。

COVID-19 的影響

支氣管鏡檢查會產生氣溶膠，使醫護人員容易受到感染。因此，正在採取措施減少病毒傳播的可能性，例如使用一次性支氣管鏡、支氣管鏡檢查前進行PCR檢測以及個人防護設備。支氣管鏡檢查服務和設備的可得性和需求受到這些實踐變化的影響。然而，效用仍存在爭議，因為支氣管鏡檢查具有顯著的感染風險。需要進一步研究來確定大流行對支氣管鏡市場的長期影響。

支氣管鏡檢查部分預計將在預測期內成為最大的部分

由於先進的支氣管鏡檢查提供了廣泛的介入治療，如切片檢查、切除技術、治療治療性介入、去除異物和支架置入，預計支氣管鏡檢查領域將出現良好的成長。由於支氣管鏡檢查在執行治療和診斷治療方面的多功能性，市場需求不斷增加。製造商生產和銷售更複雜的支氣管鏡的競爭力不斷增強，正在刺激該行業的創新。因此，公司正在努力推出新的配件、功能和技術，透過改進和差異化的產品來增加市場佔有率。

預測期內，支氣管診斷領域預期複合年成長率最高

預計支氣管診斷領域在預測期內將以最高複合年成長率成長。支氣管診斷領域協助醫生識別肺部疾病的階段、類型和特徵，以便提供個人化和針對性的治療，例如化療、放射線治療、放射標靶治療和標靶治療。醫療保健專業人員越來越依賴支氣管鏡檢查來準確、及時地診斷呼吸系統疾病，這推動了對支氣管診斷程序和支氣管鏡檢查市場的需求。

比最大的地區

預計北美在預測期內將佔據最大的市場佔有率。這是由於北美癌症發生率上升以及微創手術日益普及等因素所造成的。此外，醫學影像技術的重大開拓也推動了市場的發展，它使得標靶癌症治療成為可能，並使介入腫瘤學家能夠將影像引導治療涵蓋日常臨床實踐。此外，根據加拿大癌症協會2022年11月發布的統計數據，預計當年將有233,900名加拿大人被診斷出罹患癌症。癌症發生率的增加凸顯了預防癌症的必要性，這主要是由於加拿大的老化和人口不斷增加。

複合年成長率最高的地區：

由於政府努力增加癌症治療資金、尖端治療方法和產品的商業化以及圍繞其開發的監管支持，預計亞太地區在預測期內的複合年成長率最高。在中國、日本和印度等國家設有研究中心。此外，一些國家有前景的報銷制度和法律規範正在促進支氣管鏡手術的普及，並促進該地區的市場成長。

免費客製化服務：

如果您訂閱此報告，我們將為您提供以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球支氣管鏡市場：依產品類型

  • 支氣管鏡
    • 死板的
    • 靈活的
    • 支氣管內超音波（EBUS）

第6章全球支氣管鏡市場：依組成部分

  • 影像系統
    • 光源
    • 視訊處理器
    • 相機鏡頭
    • 無線顯示和監控
  • 配件
    • 喉舌
    • 清潔刷
    • 切片檢查閥
    • 經支氣管細針抽吸
    • 細胞刷
    • 切片檢查鉗
    • 其他配件
  • 其他組件

第7章全球支氣管鏡市場：依用途

  • 一次性的
  • 可重複使用的

第8章全球支氣管鏡市場：依應用分類

  • 支氣管治療
  • 支氣管診斷

第9章全球支氣管鏡市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 其他最終用戶

第10章全球支氣管鏡市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Boston Scientific
  • Cook Medical
  • Ethicon.Inc
  • Fujifilm Holdings Corporation
  • Olympus Corporation
  • Richard Wolf GmbH
  • Roper Technologies
  • Teleflex Incorporated.
  • Medtronic
  • Lymol Medical
  • Hoya Corporation
  • Karl Storz
  • AMBU A/S
  • Conmed Corporation
  • Broncus Medical Inc.
  • Novatech SA
  • Pentax Medical
Product Code: SMRC24818

According to Stratistics MRC, the Global Bronchoscopy Market is accounted for $2.7 billion in 2023 and is expected to reach $5.3 billion by 2030 growing at a CAGR of 9.9% during the forecast period. A bronchoscopy is a medical treatment that allows one to see and assess the lungs and airways. Bronchoscope is a device, which is a thin, flexible tube that is inserted into the mouth or nose, down the throat, and into the airways. Direct vision of the respiratory system is made possible by bronchoscopy, which enables treatment and diagnostic procedures for a range of lung diseases.

According to the Forum of International Respiratory Societies report 2022, approximately 200 million people are estimated to have COPD, and 262 million are affected by Asthma. With such a high prevalence of respiratory disease and a rise in cancer cases, the demand for bronchoscopes is expected to increase to diagnose this disease, eventually driving the market.

Market Dynamics:

Driver:

Growing burden of respiratory diseases and lung

There is a growing need for diagnostic procedures like bronchoscopies due to the rising prevalence of respiratory disorders such lung cancer, chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and TB. In addition, the bronchoscopy is essential for collecting tissue samples and assessing the airways in order to provide an appropriate diagnosis since these illnesses frequently need for precise staging and diagnosis. When it comes to lung-related illnesses, bronchoscopy presents an option to open operations as patient preferences move toward less intrusive methods boosting the market growth.

Restraint:

High production costs and difficulty in application

Elevated overhead costs might result in higher prices for procedures or levies to pay for these outlays. This may have an adverse effect on healthcare budgets and affordability for payers and patients equally by raising expenses for patients, insurance companies, or government healthcare programs. There may be an unequal distribution of bronchoscopy services, with fewer hospitals providing these procedures, in areas where overhead costs are too high. Patient treatment may be impacted by differences in availability to sophisticated diagnostic and therapeutic bronchoscopy services as a result of this.

Opportunity:

Technological advancements in bronchoscopy

Various therapeutic treatments within the airways, including ablation methods, bronchial thermoplasty, biopsies, stent placements, tumor removal, and the removal of foreign materials, are made possible by advanced bronchoscope technology. These features raise the bronchoscopy's utility for therapeutic applications and broaden its application beyond diagnosis. Furthermore, the comprehensive, real-time imaging of the airways and surrounding structures is made possible by virtual bronchoscopy and modern imaging modalities including electromagnetic navigation bronchoscopy (ENB) and endobronchial ultrasound (EBUS) thereby encouraging in the market growth.

Threat:

Risk of complications

Healthcare institutions and providers may face legal and liability issues as a result of complications following bronchoscopy operations. The adherence to stringent standards of care and protocols by healthcare practitioners is necessary in order to mitigate difficulties and prevent potential lawsuits. This adds to the intricacy and caution associated with executing these treatments. Instances of problems might draw regulatory attention, leading authorities to enforce more stringent policies or quality control processes for bronchoscopy operations. To remain compliant, healthcare institutions could have to show that they are following strict guidelines, which might have an impact on how well they operate and how they use their resources impeding the growth of the market.

Covid-19 Impact

Healthcare personnel are more vulnerable to infection during bronchoscopy procedures because of their aerosol-generating nature. Consequently, steps have been taken to lower the possibility of viral transmission, including the use of disposable bronchoscopes, pre-bronchoscopy PCR testing, and personal protective equipment. The availability and demand for bronchoscopy services and equipment have been impacted by these changes in practice. However, because bronchoscopy has a considerable risk of infection, its usefulness in diagnosing COVID-19 is still up for discussion. To determine the pandemic's long-term effects on the bronchoscopy market, more investigation is required.

The bronchoscopes segment is expected to be the largest during the forecast period

The bronchoscopes segment is estimated to have a lucrative growth, because advanced bronchoscopes provide a broad spectrum of interventional treatments, including biopsies, ablative methods, therapeutic interventions, foreign body removal, and stent installation. The market demand for bronchoscopes has increased due to its versatility in conducting both therapeutic and diagnostic treatments. Industry innovation has been spurred by manufacturers' increased competitiveness to create and market more sophisticated bronchoscopes thus businesses work hard to launch new accessories, features, and technology in an effort to expand their market share through improved and differentiated products.

The bronchial diagnosis segment is expected to have the highest CAGR during the forecast period

The bronchial diagnosis segment is anticipated to witness the highest CAGR growth during the forecast period, in order to provide individualized and targeted therapies, such as surgery, chemotherapy, radiation, or targeted therapies; it assists doctors in identifying the stage, type, and features of lung illnesses. Healthcare professionals are increasingly depending on bronchoscopy for precise and timely diagnosis of respiratory disorders, which is driving the demand for bronchial diagnostic procedures and the bronchoscopy market.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to factors like the rising incidence of cancer in the nation, the growing popularity of minimally invasive procedures. Moreover, the market is being driven by the fact that notable developments in medical imaging technology have made targeted cancer therapy possible and enabled interventional oncologists to incorporate image-guided treatments into routine clinical practice. In addition, statistics released by the Canadian Cancer Society in November 2022 predicted that 233,900 Canadians will receive a cancer diagnosis that year. The need of cancer prevention is highlighted by this increase in incidence, which is mostly attributable to Canada's aging and expanding population.

Region with highest CAGR:

Asia-Pacific is projected to have the highest CAGR over the forecast period, owing to government's initiatives to increase funding for cancer treatments, the commercialization of cutting-edge procedures and products and the supportive regulations surrounding their development, rising healthcare spending, and the expansion of research bases in nations such as China, Japan, and India. Additionally the promising reimbursement systems and regulatory frameworks in several nations have facilitated the uptake of bronchoscopy operations encourage the growth of the market in this region.

Key players in the market

Some of the key players profiled in the Bronchoscopy Market include Boston Scientific, Cook Medical, Ethicon.Inc, Fujifilm Holdings Corporation, Olympus Corporation, Richard Wolf GmbH, Roper Technologies, Teleflex Incorporated., Medtronic, Lymol Medical, Hoya Corporation, Karl Storz, AMBU A/S, Conmed Corporation, Broncus Medical Inc., Novatech SA and Pentax Medical

Key Developments:

In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain.

In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity™ blood pressure procedure, for the treatment of hypertension.

In September 2023, Boston Scientific announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.

Product Types Covered:

  • Bronchoscopes

Components Covered:

  • Imaging Systems
  • Accessories
  • Other Components

Usages Covered:

  • Disposable
  • Reusable

Applications Covered:

  • Bronchial Treatment
  • Bronchial Diagnosis

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bronchoscopy Market, By Product Type

  • 5.1 Introduction
  • 5.2 Bronchoscopes
    • 5.2.1 Rigid
    • 5.2.2 Flexible
    • 5.2.3 Endobronchial Ultrasound (EBUS)

6 Global Bronchoscopy Market, By Component

  • 6.1 Introduction
  • 6.2 Imaging Systems
    • 6.2.1 Light Sources
    • 6.2.2 Video Processors
    • 6.2.3 Camera Heads
    • 6.2.4 Wireless Displays & Monitors
  • 6.3 Accessories
    • 6.3.1 Mouthpieces
    • 6.3.2 Cleaning Brushes
    • 6.3.3 Biopsy Valves
    • 6.3.4 Transbronchial Aspiration Needles
    • 6.3.5 Cytology Brushes
    • 6.3.6 Biopsy Forceps
    • 6.3.7 Other Accessories
  • 6.4 Other Components

7 Global Bronchoscopy Market, By Usage

  • 7.1 Introduction
  • 7.2 Disposable
  • 7.3 Reusable

8 Global Bronchoscopy Market, By Application

  • 8.1 Introduction
  • 8.2 Bronchial Treatment
  • 8.3 Bronchial Diagnosis

9 Global Bronchoscopy Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgery Centers
  • 9.4 Other End Users

10 Global Bronchoscopy Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Boston Scientific
  • 12.2 Cook Medical
  • 12.3 Ethicon.Inc
  • 12.4 Fujifilm Holdings Corporation
  • 12.5 Olympus Corporation
  • 12.6 Richard Wolf GmbH
  • 12.7 Roper Technologies
  • 12.8 Teleflex Incorporated.
  • 12.9 Medtronic
  • 12.10 Lymol Medical
  • 12.11 Hoya Corporation
  • 12.12 Karl Storz
  • 12.13 AMBU A/S
  • 12.14 Conmed Corporation
  • 12.15 Broncus Medical Inc.
  • 12.16 Novatech SA
  • 12.17 Pentax Medical

List of Tables

  • Table 1 Global Bronchoscopy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bronchoscopy Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Bronchoscopy Market Outlook, By Bronchoscopes (2021-2030) ($MN)
  • Table 4 Global Bronchoscopy Market Outlook, By Rigid (2021-2030) ($MN)
  • Table 5 Global Bronchoscopy Market Outlook, By Flexible (2021-2030) ($MN)
  • Table 6 Global Bronchoscopy Market Outlook, By Endobronchial Ultrasound (EBUS) (2021-2030) ($MN)
  • Table 7 Global Bronchoscopy Market Outlook, By Component (2021-2030) ($MN)
  • Table 8 Global Bronchoscopy Market Outlook, By Imaging Systems (2021-2030) ($MN)
  • Table 9 Global Bronchoscopy Market Outlook, By Light Sources (2021-2030) ($MN)
  • Table 10 Global Bronchoscopy Market Outlook, By Video Processors (2021-2030) ($MN)
  • Table 11 Global Bronchoscopy Market Outlook, By Camera Heads (2021-2030) ($MN)
  • Table 12 Global Bronchoscopy Market Outlook, By Wireless Displays & Monitors (2021-2030) ($MN)
  • Table 13 Global Bronchoscopy Market Outlook, By Accessories (2021-2030) ($MN)
  • Table 14 Global Bronchoscopy Market Outlook, By Mouthpieces (2021-2030) ($MN)
  • Table 15 Global Bronchoscopy Market Outlook, By Cleaning Brushes (2021-2030) ($MN)
  • Table 16 Global Bronchoscopy Market Outlook, By Biopsy Valves (2021-2030) ($MN)
  • Table 17 Global Bronchoscopy Market Outlook, By Transbronchial Aspiration Needles (2021-2030) ($MN)
  • Table 18 Global Bronchoscopy Market Outlook, By Cytology Brushes (2021-2030) ($MN)
  • Table 19 Global Bronchoscopy Market Outlook, By Biopsy Forceps (2021-2030) ($MN)
  • Table 20 Global Bronchoscopy Market Outlook, By Other Accessories (2021-2030) ($MN)
  • Table 21 Global Bronchoscopy Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 22 Global Bronchoscopy Market Outlook, By Usage (2021-2030) ($MN)
  • Table 23 Global Bronchoscopy Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 24 Global Bronchoscopy Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 25 Global Bronchoscopy Market Outlook, By Application (2021-2030) ($MN)
  • Table 26 Global Bronchoscopy Market Outlook, By Bronchial Treatment (2021-2030) ($MN)
  • Table 27 Global Bronchoscopy Market Outlook, By Bronchial Diagnosis (2021-2030) ($MN)
  • Table 28 Global Bronchoscopy Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Bronchoscopy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 Global Bronchoscopy Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 31 Global Bronchoscopy Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.